Contrast-induced nephropathy risk due to emergency contrast-enhanced computed tomography

European Journal of Emergency Medicine

Volumn 19, Issue 1, 2012, Pages 20-23

  Durukan, Polat ^a   Ozkan, Seda ^a   Ikizceli, Ibrahim ^a   Vardar, Alper ^a   Ipekci, Afsin ^a   Duman, Ali ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

computed tomography; contrast media; emergency; nephropathy

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EMERGENCY WARD; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UREA BLOOD LEVEL;

CONTRAST MEDIA; CREATININE; EMERGENCY MEDICAL SERVICES; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH STATUS INDICATORS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; UREA;

EID: 84855794796     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/MEJ.0b013e32834749b3     Document Type: Article

References (23)

1. Chong E, Zed PJ. N-acetylcysteine for radiocontrast-induced nephropathy: potential role in the emergency department? Can J Emerg Med 2004; 6:253-258. (Pubitemid 40631967)
2. Sharma SK, Kini A. Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials. Catheter Cardiovasc Interv 2005; 65:386-393. (Pubitemid 40898183)
3. Band RA, Gaieski DF, Mills AM, Sease KL, Shofer FS, Robey JL, Hollander JE. Discordance between serum creatinine and creatinine clearance for identification of ED patients with abdominal pain at risk for contrast-induced nephropathy. Am J Emerg Med 2007; 25:268-272. (Pubitemid 46356858)
4. Barrett BJ, Parfrey PS. Clinical practice: preventing nephropathy induced by contrast medium. N Engl J Med 2006; 534:379-386. (Pubitemid 43145062)
5. McCullough PA, Wolyn R, Rocher LL, Levin RN, ONeill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103:368-375. (Pubitemid 27506242)
6. Isenbarger DW, Kent SM, OMalley PG. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 2003; 92:1454-1458. (Pubitemid 37532572)
7. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44:1343-1349.
8. Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA, et al. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 2008; 248:97-105.
9. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial, the iohexol cooperative study. Kidney Int 1995; 47:254-261.
10. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996; 275:1489-1494. (Pubitemid 26140761)
11. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006; 98:5K-13K.
12. Murakami R, Tajima H, Kumazaki T, Yamamoto K. Effect of iodixanol on renal function immediately after abdominal angiography: clinical comparison with iomeprol and ioxaglate. Acta Radiol 1998; 39:368-371. (Pubitemid 128451550)
13. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89:615-620. (Pubitemid 20384319)
14. Cigarroa RG, Lange RA,Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86:649-652. (Pubitemid 19149343)
15. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol 1991; 157:49-58.
16. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188:171-178. (Pubitemid 23183119)
17. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994; 5:125-137. (Pubitemid 24977068)
18. Ashley JB, Millward SF. Contrast agent-induced nephropathy: a simple way to identify patients with preexisting renal insufficiency. AJR Am J Roentgenol 2003; 181:451-454. (Pubitemid 36909489)
19. Stevents LA, Coresh J, Grene T, Levey AS. Assessing kidney function measured and estimated glomerular filtration rate. N Engl J Med 2006; 354:2473-2483. (Pubitemid 43855050)
20. Duncan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant 2001; 16:1042-1046. (Pubitemid 32440380)
21. Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrastinduced nephropathy. A comparison of 3 regimens for protecting contrastinduced nephropathy in patients undergoing coronary procedures: a singlecenter prospective controlled trial. Am Heart J 2007; 154:539-544. (Pubitemid 47268251)
22. Taylor AJ, Hotchkiss D, Morse RW, McCabe J. Preparation for angiography in renal dysfunction: a randomized trial of inpatient versus outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 1998; 114:1570-1574. (Pubitemid 128487477)
23. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162:329-336. (Pubitemid 34127411)